Danaher Corporation, a key player in Life Sciences, Biotechnology, and Diagnostics, has shown mixed financial performance with recent declines in revenue and net earnings. Despite recent struggles ...

Arkadios Wealth Advisors trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 6.1% in the 4th quarter, ...

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2024 performance in a ...

Danaher Diagnostics LLC and Danaher Ventures LLC, two subsidiaries of Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, announced today that they have formed an ...

Danaher Corporation (NYSE:DHR), a global science and technology innovator, has been navigating a complex market landscape in recent months. According to InvestingPro analysis, the company is ...

Diagnostics and Danaher Ventures, two subsidiaries of Danaher Corporation, announced that they have formed an investment ...

Stock analysts at William Blair decreased their Q3 2025 earnings per share estimates for Danaher in a note issued to investors on Monday, January 13th. William Blair analyst M. Larew now expects that ...

two subsidiaries of Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, announced today that they have formed an investment partnership with Innovaccer Inc., a ...